Design, synthesis, biological evaluation and molecular modeling of N-isobutyl-N-((2-(p-tolyloxymethyl)thiazol-4yl)methyl)benzo[d][1,3] dioxole-5-carboxamides as selective butyrylcholinesterase inhibitors.
Bioorg Med Chem Lett
; 61: 128602, 2022 04 01.
Article
in En
| MEDLINE
| ID: mdl-35124202
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Butyrylcholinesterase
/
Drug Design
/
Cholinesterase Inhibitors
/
Alzheimer Disease
Limits:
Humans
Language:
En
Journal:
Bioorg Med Chem Lett
Year:
2022
Document type:
Article